Entero Healthcare
Ticker >

Entero Healthcare share price

Entero Healthcare Solutions Ltd.

NSE: ENTERO BSE: 544122 SECTOR: Trading  6605   2   0

1496.70
-7.25 (-0.48%)
NSE: Today, 11:34 AM

Price Summary

Today's High

₹ 1505

Today's Low

₹ 1485

52 Week High

₹ 1510.9

52 Week Low

₹ 970

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 6509.71 Cr.

Enterprise Value

₹ 6777.18 Cr.

No. of Shares

4.35 Cr.

P/E

166.45

P/B

3.93

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  380.93

CASH

₹ 106.84 Cr.

DEBT

₹ 374.32 Cr.

Promoter Holding

52.44 %

EPS (TTM)

₹  8.99

Sales Growth

0

ROE

ROCE

Profit Growth

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Index Presence

The company is present in 1 Indices.

BSEIPO

S&P Bse IPO
16835.16
  23.9599999999991 (0.142524031597979%)

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year18.85%
3 Year30.14%
5 YearNA

Profit Growth

1 Year458.42%
3 Year66.22%
5 YearNA

ROE%

1 Year5.08%
3 Year1.69%

ROCE %

1 Year7.02%
3 Year4.42%

Debt/Equity

0.1684

Price to Cash Flow

-143.65

Interest Cover Ratio

0

CFO/PAT (5 Yr. Avg.)

0

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2024 52.44 0
Mar 2024 52.44 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 30.1350304382573% for the Past 3 years.
  • The company has an efficient Cash Conversion Cycle of 0 days.
  • The company has a high promoter holding of 52.44%.
  • Promoter stake has increased from 0% to 52.44% in the last 1 quarter.

 Limitations

  • The company has shown a poor profit growth of 0% for the Past 3 years.
  • Company has a poor ROE of 1.69246666666667% over the past 3 years.
  • Company has a poor ROCE of 4.41887908194505% over the past 3 years
  • Company has low Interest coverage ratio of 0.
  • Company has negative cash flow from operations of -36.612.
  • Tax rate is low at 0.
  • The company has a low EBITDA margin of 0% over the past 5 years.
  • The company has negative book value.
  • The company is trading at a high EV/EBITDA of 46.6316.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2023 Mar 2024 Jun 2024
Net Sales 992.63 1034.18 1097.04
Total Expenditure 964.03 1005.3 1066.86
Operating Profit 28.6 28.88 30.17
Other Income 1.79 9.15 13.44
Interest 16.07 17.32 9.7
Depreciation 5.99 7.14 6.61
Exceptional Items 0 0 0
Profit Before Tax 8.32 13.56 27.3
Tax 1.34 -7.62 6.77
Profit After Tax 6.98 21.18 20.53
Adjustments -0.2 -0.21 -0.45
Consolidated Net Profit 6.78 20.97 20.08
Adjusted EPS (Rs) 4.22 4.82 4.62

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 1779.74 2522.07 3300.21 3922.31
Total Expenditure 1758.19 2497.63 3236.2 3810.47
Operating Profit 21.55 24.44 64.01 111.84
Other Income 3.93 4.48 5.51 14.41
Interest 20.04 28.98 48.97 65.68
Depreciation 16.28 19.75 24.24 25.02
Exceptional Items 0 0 0 0
Profit Before Tax -10.84 -19.81 -3.69 35.56
Tax 4.52 9.63 7.42 -4.24
Profit After Tax -15.35 -29.44 -11.1 39.8
Adjustments -0.18 -0.48 -0.45 -0.69
Consolidated Net Profit -15.54 -29.92 -11.56 39.11
Adjusted EPS (Rs.) -1553.7 -77.71 -28.11 8.99

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 517.21 622.84 667.73 43.49
Total Reserves -31.85 -61.8 -72.7 1594.56
Minority Interest 1.69 2.18 2.63 3.33
Borrowings 0 74.25 31.07 45.54
Other N/C liabilities 57.27 63.18 54.04 37.08
Current liabilities 289.13 461.78 623.96 601.95
Total Liabilities 833.46 1125.31 1306.72 2325.95
Assets
Net Block 188.57 261.97 267.73 289.34
Capital WIP 0 0.59 0 0
Intangible WIP 2.24 0.05 0 0
Investments 0 0 0 0
Loans & Advances 9.72 11.82 14.42 20.2
Other N/C Assets 0 0 1.4 5.44
Current Assets 632.92 850.88 1023.17 2010.98
Total Assets 833.46 1125.31 1306.72 2325.95
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations -10.84 -19.81 -3.69 35.56
Adjustment 42.66 41.52 71.16 86.62
Changes in Assets & Liabilities -95.93 -46.07 -100.36 -145.73
Tax Paid -4.58 -10.9 -12.43 -13.06
Operating Cash Flow -68.68 -35.27 -45.32 -36.61
Investing Cash Flow -30.87 -161.73 -48.6 -704.04
Financing Cash Flow 88.71 211.19 72.76 862.94
Net Cash Flow -10.84 14.19 -21.15 122.28

Corporate Actions

Investors Details

PARTICULARS Mar 2024% Jun 2024%
promoters 52.44 52.44
orbimed asia iii mauritiu... 38.03 38.03
prabhat agrawal 9.26 9.26
prem sethi 5.15 5.15
PARTICULARS Mar 2024% Jun 2024%
investors 47.56 47.56
clsa global markets pte. ... 5.45 4.76
government of singapore 5.03 5.93
llp - 0.02
smallcap world fund, inc 4.04 4.60
surbhi singh - prasid uno... - 15.98
prasid uno family trust (... 15.98 -

Annual Reports

Ratings & Research Reports

Company Presentations

Last Updated on:
Brief about Entero Healthcare
X